S3800 Genetic testing for amyotrophic lateral sclerosis (als)
Billable / valid for submission HCPCS Release 2026Q3
Short description: Genetic testing als
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Genetic testing for amyotrophic lateral sclerosis (als) | yes |
Related codes in S38
- S3840 Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
- S3841 Genetic testing for retinoblastoma
- S3842 Genetic testing for von hippel-lindau disease
- S3844 Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
- S3845 Genetic testing for alpha-thalassemia
- S3846 Genetic testing for hemoglobin e beta-thalassemia
- S3849 Genetic testing for niemann-pick disease
- S3850 Genetic testing for sickle cell anemia
- S3852 Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
- S3853 Genetic testing for myotonic muscular dystrophy
- S3854 Gene expression profiling panel for use in the management of breast cancer treatment
- S3861 Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome
- S3865 Comprehensive gene sequence analysis for hypertrophic cardiomyopathy
- S3866 Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
- S3870 Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability